Atlas Trials

A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.

Clinical trial NCT00636246 · COMPLETED

Trial details

NCT number
NCT00636246
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2004-06-01
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.